Abusy month in product launches included a new CE-marked IVD version of Invivoscribe Technologies’ LeukoStrat CDx FLT3 Mutation Assay, which the company describes as the first companion diagnostic for acute myeloid leukemia. The assay also secured FDA approval earlier this year. Helix had a busy month. In addition to partnering with Illumina Accelerator to provide…
The Dx Pipeline: A Roundup of the Month’s Key New Product Launches
Abusy month in product launches included a new CE-marked IVD version of Invivoscribe Technologies’ LeukoStrat CDx FLT3 Mutation Assay, which the company describes as the first companion diagnostic for acute myeloid leukemia. The assay also secured FDA approval earlier this year. Helix had a busy month. In addition to partnering with Illumina Accelerator to provide […]